NDAC
This article was originally published in The Tan Sheet
Executive Summary
Meeting tentatively scheduled for Dec. 13-14, although no agenda has been released. NDAC most recently met jointly with Pulmonary-Allergy Drugs Advisory Committee May 11 to consider OTC switch potential of low- and non-sedating antihistamines (1"The Tan Sheet" May 14, p. 3 and 2May 21, pp. 12-14)